➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Colorcon
Baxter
McKesson
Express Scripts

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Claims for Patent: 9,224,312

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,224,312
Title:Methods and devices for determining sensing device usability
Abstract: Methods and devices for determining sensing device usability, e.g., for point of care immunoassay devices. In one embodiment, the invention is to a method of determining device usability, comprising the steps of providing a device comprising a first electrical pad; a second electrical pad; and a continuous polymer layer contacting at least a portion of the first and second electrical pads; applying a potential across the first and second electrical pads; measuring an electrical property associated with the continuous polymer layer; and determining whether the measured electrical property associated with the continuous polymer layer has exceeded a threshold level associated with the device usability.
Inventor(s): Martin; Glenn (Ottawa, CA), Zhao; Tian-Xian (Ottawa, CA), Breeze; Steven (Ottawa, CA), Jeffrey; Craig (Ottawa, CA), Snyder; Stephen Lee (Ottawa, CA)
Assignee: Abbott Point of Care Inc. (Princeton, NJ)
Application Number:13/538,148
Patent Claims:1. A method of determining device usability, comprising the steps of: providing a device comprising a first electrical pad; a second electrical pad; and a continuous polymer layer contacting at least a portion of the first and second electrical pads; applying, by an instrument, a potential across the first and second electrical pads; measuring, by the instrument, an electrical property associated with the continuous polymer layer; determining, by the instrument, whether the measured electrical property associated with the continuous polymer layer has exceeded a threshold level associated with the device usability; and determining, by the instrument, the device is valid for use when the measured electrical property associated with the continuous polymer layer does not exceed the threshold level, wherein the continuous polymer layer comprises a polymer matrix, a plasticizer and an organic salt, and wherein the continuous polymer layer comprises from 20 to 40 wt.% polymer matrix.

2. The method of claim 1, wherein the polymer matrix comprises a polymer selected from the group consisting of polyvinyl chloride (PVC), polyurethane, polyvinylacetate, carboxylated PVC, hydroxylated PVC and polydimethyl siloxane.

3. The method of claim 1, wherein the continuous polymer layer comprises from 60 to 80% plasticizer.

4. The method of claim 1, wherein the plasticizer is selected from the group consisting of trioctyl phosphate (TOP), nitrophenyloctyl ether (NPOE), bisethylhexylsebacate (BEHS), trimethyl trimellitate (TMTT), dioctyl adipate (DOA) and diisobutyl phthalate (DIBP).

5. The method of claim 1, wherein the electrical property comprises current, resistance, impedance, conductivity, or a combination thereof.

6. The method of claim 1, wherein the distance between the first and second electrical pads is from 10 .mu.m to 2 mm.

7. The method of claim 1, wherein the potential comprises a sigmoidal potential cycle, a fixed applied potential, a sequence of fixed applied potential steps, or a combination thereof.

8. The method of claim 1, wherein the potential comprises a potential cycle that is applied at a predetermined frequency in the range of about 1 Hz to about 100 Hz.

9. The method of claim 1, further comprising inserting the device into the instrument configured to determine whether the measured electrical property associated with the continuous polymer layer has exceeded the threshold level associated with the device usability.

10. The method of claim 1, where the device further comprises a sensor selected from the group consisting of a pH sensor, oxygen sensor, carbon dioxide sensor, hematocrit sensor, glucose sensor, lactate sensor, creatinine sensor, sodium sensor, potassium sensor, magnesium sensor, calcium sensor, chloride sensor, phosphate sensor, liver enzyme sensor, B-type Natriuretic Peptide (BNP) sensor, troponin sensor, blood urea nitrogen (BUN) sensor, creatine kinase myocardial b fraction (CKMB) sensor, neutrophil gelatinase associated lipocalin (NGAL) sensor, thyroid stimulating hormone (TSH) sensor, D-dimer sensor, prostate specific antigen (PSA) sensor, parathyroid hormone (PTH) sensor, cholesterol sensor, alanine transaminase (ALT) sensor, aspartate aminotransferase (AST) sensor, prothrombin sensor, activated partial thromboplastin time (APTT) sensor, activated clotting time (ACT) sensor, galectin sensor, and combinations thereof.

11. A method of determining device usability, comprising the steps of: providing a device comprising a first electrical pad; a second electrical pad; and a continuous polymer layer contacting at least a portion of the first and second electrical pads; applying, by an instrument, a potential across the first and second electrical pads; measuring, by the instrument, an electrical property associated with the continuous polymer layer; determining, by the instrument, whether the measured electrical property associated with the continuous polymer layer has exceeded a threshold level associated with the device usability; and determining, by the instrument, the device is valid for use when the measured electrical property associated with the continuous polymer layer does not exceed the threshold level, wherein the continuous polymer layer comprises a polymer matrix, a plasticizer and an organic salt, and wherein the continuous polymer layer comprises from 0.1 to 10 wt.% of the organic salt.

12. The method of claim 11, wherein the organic salt is selected from the group consisting of quaternary ammonium tetrakis phenylborate, dodecyl sulfosuccinate, lauryl sulfate, alkyl ether phosphates, benzylkonium, cetylpyrdinium dodecyl sulfosuccinate, lauryl sulfate, alkyl ether phosphates, tetramethylammonium, benzylkonium, cetylpyrdinium, an iodide, a bromide, a perchlorate, a zwitterionic compound, cocamidopropyl hydroxysultaine and quaternary ammonium borate.

13. A method of determining device usability, comprising the steps of: providing a device comprising a first electrical pad; a second electrical pad; and a continuous polymer layer contacting at least a portion of the first and second electrical pads; applying, by an instrument, a potential across the first and second electrical pads; measuring, by the instrument, an electrical property associated with the continuous polymer layer; determining, by the instrument, whether the measured electrical property associated with the continuous polymer layer has exceeded a threshold level associated with the device usability; and determining, by the instrument, the device is valid for use when the measured electrical property associated with the continuous polymer layer does not exceed the threshold level, wherein the continuous polymer layer comprises a polymer matrix, a plasticizer and an organic salt, and wherein the continuous polymer layer is substantially circular and has a diameter of from about 20 .mu.m to about 2 mm.

14. The method of claim 13, wherein the device further comprises a boundary structure for controlling the spreading of a dispensed polymer layer precursor to a predetermined region of the device.

15. The method of claim 13, wherein the device further comprises a boundary structure for controlling the spreading of a dispensed liquid to a predetermined region of the device, wherein the boundary structure comprises a ring intersecting said first and second contact pads.

16. The method of claim 13, wherein the first and second pads are separated by a distance of from about 10 .mu.m to about 2 mm.

17. A method of determining device usability, comprising the steps of: providing a device comprising a first electrical pad; a second electrical pad; and a continuous polymer layer contacting at least a portion of the first and second electrical pads; applying, by an instrument, a potential across the first and second electrical pads; measuring, by the instrument, an electrical property associated with the continuous polymer layer; determining, by the instrument, whether the measured electrical property associated with the continuous polymer layer has exceeded a threshold level associated with the device usability; and determining, by the instrument, the device is valid for use when the measured electrical property associated with the continuous polymer layer does not exceed the threshold level, wherein the continuous polymer layer comprises a polymer matrix, a plasticizer and an organic salt, wherein the first and second pads are separated by a distance of from about 10 .mu.m to about 2 mm, and wherein the continuous polymer layer is domed.

18. A method of determining device usability, comprising the steps of: measuring an initial current value associated with a continuous polymer layer when a device is manufactured; providing the device comprising a first electrical pad; a second electrical pad; and the continuous polymer layer contacting at least a portion of the first and second electrical pads; applying, by an instrument, a potential across the first and second electrical pads; measuring, by the instrument, an electrical property associated with the continuous polymer layer; determining, by the instrument, whether the measured electrical property associated with the continuous polymer layer has exceeded a threshold level associated with the device usability; and determining, by the instrument, the device is valid for use when the measured electrical property associated with the continuous polymer layer does not exceed the threshold level, wherein the electrical property comprises current, and wherein the threshold level is at least five times lower than initial current value.

19. A method of determining device usability, comprising the steps of: measuring an initial impedance value associated with a continuous polymer layer when a device is manufactured; providing the device comprising a first electrical pad; a second electrical pad; and the continuous polymer layer contacting at least a portion of the first and second electrical pads; applying, by an instrument, a potential across the first and second electrical pads; measuring, by the instrument, an electrical property associated with the continuous polymer layer; determining, by the instrument, whether the measured electrical property associated with the continuous polymer layer has exceeded a threshold level associated with the device usability; and determining, by the instrument, the device is valid for use when the measured electrical property associated with the continuous polymer layer does not exceed the threshold level, wherein the electrical property comprises current, and wherein the threshold level is at least five times greater than the initial impedance.

20. A device having a usability threshold, comprising a first electrical pad, a second electrical pad, and a continuous polymer layer contacting at least a portion of the first and second electrical pads, wherein the continuous polymer layer has an electrical property associated with the device usability threshold, wherein the continuous polymer layer comprises a polymer matrix, a plasticizer and an organic salt, and wherein the continuous polymer layer comprises from 20 to 40 wt.% polymer matrix.

21. The device of claim 20, wherein the polymer matrix comprises a polymer selected from the group consisting of polyvinyl chloride (PVC), polyurethane, polyvinylacetate, carboxylated PVC, hydroxylated PVC and polydimethyl siloxane.

22. The device of claim 20, wherein the polymer layer comprises from 60 to 80% plasticizer.

23. The device of claim 20, wherein the plasticizer is selected from the group consisting of trioctyl phosphate (TOP), nitrophenyloctyl ether (NPOE), bisethylhexylsebacate (BEHS), trimethyl trimellitate (TMTT), dioctyl adipate (DOA) and diisobutyl phthalate (DIBP).

24. A device having a usability threshold, comprising a first electrical pad, a second electrical pad, and a continuous polymer layer contacting at least a portion of the first and second electrical pads, wherein the continuous polymer layer has an electrical property associated with the device usability threshold, wherein the continuous polymer layer comprises a polymer matrix, a plasticizer and an organic salt, and wherein the continuous polymer layer comprises from 0.1 to 10 wt.% of the organic salt.

25. The device of claim 24, wherein the organic salt is selected from the group consisting of quaternary ammonium tetrakis phenylborate, dodecyl sulfosuccinate, lauryl sulfate, alkyl ether phosphates, benzylkonium, cetylpyrdinium dodecyl sulfosuccinate, lauryl sulfate, alkyl ether phosphates, tetramethylammonium, benzylkonium, cetylpyrdinium, an iodide, a bromide, a perchlorate, a zwitterionic compound, cocamidopropyl hydroxysultaine and quaternary ammonium borate.

26. A device having a usability threshold, comprising a first electrical pad, a second electrical pad, and a continuous polymer layer contacting at least a portion of the first and second electrical pads, wherein the continuous polymer layer has an electrical property associated with the device usability threshold, wherein the continuous polymer layer comprises a polymer matrix, a plasticizer and an organic salt, and wherein the continuous polymer layer is substantially circular and has a diameter of from about 20 .mu.m to about 2 mm.

27. The device of claim 26, further comprising a boundary structure for controlling the spreading of a dispensed polymer layer precursor to a predetermined region of the device.

28. The device of claim 26, further comprising a boundary structure for controlling the spreading of a dispensed liquid to a predetermined region of the device, wherein the boundary structure comprises a ring intersecting said first and second contact pads.

29. The device of claim 26, wherein the first and second pads are separated by a distance of from about 10 .mu.m to about 2 mm.

30. A device having a usability threshold, comprising a first electrical pad, a second electrical pad, and a continuous polymer layer contacting at least a portion of the first and second electrical pads, wherein the continuous polymer layer has an electrical property associated with the device usability threshold, wherein the continuous polymer layer comprises a polymer matrix, a plasticizer and an organic salt, and wherein the continuous polymer layer is domed.

31. The device of claim 30, wherein the distance between the first and second electrical pads is from 10 .mu.m to 2 mm.

32. The device of claim 30, further comprising a sensor selected from the group consisting of a pH sensor, oxygen sensor, carbon dioxide sensor, hematocrit sensor, glucose sensor, lactate sensor, creatinine sensor, sodium sensor, potassium sensor, magnesium sensor, calcium sensor, chloride sensor, phosphate sensor, liver enzyme sensor, B-type Natriuretic Peptide (BNP) sensor, troponin sensor, blood urea nitrogen (BUN) sensor, creatine kinase myocardial b fraction (CKMB) sensor, neutrophil gelatinase associated lipocalin (NGAL) sensor, thyroid stimulating hormone (TSH) sensor, D-dimer sensor, prostate specific antigen (PSA) sensor, parathyroid hormone (PTH) sensor, cholesterol sensor, alanine transaminase (ALT) sensor, aspartate aminotransferase (AST) sensor, prothrombin sensor, activated partial thromboplastin time (APTT) sensor, activated clotting time (ACT) sensor, galectin sensor, and combinations thereof.

33. A method of making a device having a usability threshold, comprising the steps of: providing a substantially planar surface comprising a first electrical pad and a second electrical pad; dispensing a polymer layer precursor onto the surface, and forming from the polymer layer precursor a continuous polymer layer contacting at least a portion of the first and second electrical pads, wherein the continuous polymer layer has an electrical property associated with the device usability threshold, wherein the continuous polymer layer comprises a polymer matrix, a plasticizer and an organic salt, and wherein the continuous polymer layer comprises from 20 to 40 wt.% polymer matrix.

34. The method of claim 33, wherein the polymer layer precursor comprises an aqueous solution comprising polymer particles dispersed in water.

35. The method of claim 33, wherein the device further comprises a boundary structure that controls the region of the device where the liquid is dispensed.

36. The method of claim 35, wherein the boundary structure comprises a ring intersecting the first and second electrical pads.

37. A method of determining a threshold level associated with analytical device usability, comprising the steps of: providing a plurality of devices, each of said devices comprising a sensor; a first electrical pad; a second electrical pad; and a continuous polymer layer contacting at least a portion of the first and second electrical pads, wherein said devices have been exposed to different environmental conditions; measuring, by an instrument, an electrical property of the continuous polymer layer for each of the devices; measuring, by the instrument, a sensor signal for a control fluid for each of the devices; identifying, by the instrument, a subset of said plurality of devices that provide a signal having a predetermined acceptable precision level for said control fluid; and determining, by the instrument, the threshold level based on an initial value of the electrical property of the continuous polymer layer of a subset of said plurality of devices, wherein the continuous polymer layer comprises a polymer matrix, a plasticizer and an organic salt, and wherein the continuous polymer layer comprises from 20 to 40 wt.% polymer matrix.

38. The method of claim 37, wherein the environmental conditions include variations in at least one of time, temperature, or humidity.

39. A device comprising a sensor and a continuous polymer layer formed on a substantially planar surface, wherein the surface comprises two adjacent electrical contact pads and a space therebetween, wherein said continuous polymer layer covers at least a portion of the two electrical contact pads and a portion of said space therebetween, wherein a preselected potential or potential cycle is applied to the pads and the impedance or current associated with said continuous polymer layer is measured, said measured value is converted to a value indicative of the average shelf life time remaining for other devices from the same manufacturing lot, wherein the continuous polymer layer comprises a polymer matrix, a plasticizer and an organic salt, and wherein the continuous polymer layer comprises from 20 to 40 wt.% polymer matrix.

Details for Patent 9,224,312

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23   Start Trial Abbott Point of Care Inc. (Princeton, NJ) 2031-06-30 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23   Start Trial Abbott Point of Care Inc. (Princeton, NJ) 2031-06-30 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23   Start Trial Abbott Point of Care Inc. (Princeton, NJ) 2031-06-30 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23   Start Trial Abbott Point of Care Inc. (Princeton, NJ) 2031-06-30 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 9,224,312

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Express Scripts
Dow
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.